Global Neurological Biomarkers Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience, and cardiovascular disease.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Neurological Biomarkers market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Neurological Biomarkers market are covered in Chapter 9:
QIAGEN
Aepodia
Athena Diagnostics
Quanterix
AbaStar MDx
Acumen Pharmaceuticals
Myriad RBM
Cisbio Bioassays
Proteome Sciences
ImmunArray
Abiant
Thermo Fisher Scientific
In Chapter 5 and Chapter 7.3, based on types, the Neurological Biomarkers market from 2017 to 2027 is primarily split into:
Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
In Chapter 6 and Chapter 7.4, based on applications, the Neurological Biomarkers market from 2017 to 2027 covers:
Hospitals
Clinics
Diagnostic and research laboratories
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Neurological Biomarkers market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Neurological Biomarkers Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW
1.1 Product Overview and Scope of Neurological Biomarkers Market
1.2 Neurological Biomarkers Market Segment by Type
1.2.1 Global Neurological Biomarkers Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neurological Biomarkers Market Segment by Application
1.3.1 Neurological Biomarkers Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neurological Biomarkers Market, Region Wise (2017-2027)
1.4.1 Global Neurological Biomarkers Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.3 Europe Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.4 China Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.5 Japan Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.6 India Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.8 Latin America Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neurological Biomarkers Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neurological Biomarkers (2017-2027)
1.5.1 Global Neurological Biomarkers Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neurological Biomarkers Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neurological Biomarkers Market
2 INDUSTRY OUTLOOK
2.1 Neurological Biomarkers Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neurological Biomarkers Market Drivers Analysis
2.4 Neurological Biomarkers Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neurological Biomarkers Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neurological Biomarkers Industry Development
3 GLOBAL NEUROLOGICAL BIOMARKERS MARKET LANDSCAPE BY PLAYER
3.1 Global Neurological Biomarkers Sales Volume and Share by Player (2017-2022)
3.2 Global Neurological Biomarkers Revenue and Market Share by Player (2017-2022)
3.3 Global Neurological Biomarkers Average Price by Player (2017-2022)
3.4 Global Neurological Biomarkers Gross Margin by Player (2017-2022)
3.5 Neurological Biomarkers Market Competitive Situation and Trends
3.5.1 Neurological Biomarkers Market Concentration Rate
3.5.2 Neurological Biomarkers Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROLOGICAL BIOMARKERS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neurological Biomarkers Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neurological Biomarkers Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neurological Biomarkers Market Under COVID-19
4.5 Europe Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neurological Biomarkers Market Under COVID-19
4.6 China Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neurological Biomarkers Market Under COVID-19
4.7 Japan Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neurological Biomarkers Market Under COVID-19
4.8 India Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neurological Biomarkers Market Under COVID-19
4.9 Southeast Asia Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neurological Biomarkers Market Under COVID-19
4.10 Latin America Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neurological Biomarkers Market Under COVID-19
4.11 Middle East and Africa Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neurological Biomarkers Market Under COVID-19
5 GLOBAL NEUROLOGICAL BIOMARKERS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neurological Biomarkers Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neurological Biomarkers Revenue and Market Share by Type (2017-2022)
5.3 Global Neurological Biomarkers Price by Type (2017-2022)
5.4 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Alzheimer's disease (AD) (2017-2022)
5.4.2 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Multiple sclerosis (MS) (2017-2022)
5.4.3 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Parkinson's disease (PD) (2017-2022)
5.4.4 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
6 GLOBAL NEUROLOGICAL BIOMARKERS MARKET ANALYSIS BY APPLICATION
6.1 Global Neurological Biomarkers Consumption and Market Share by Application (2017-2022)
6.2 Global Neurological Biomarkers Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neurological Biomarkers Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2017-2022)
7 GLOBAL NEUROLOGICAL BIOMARKERS MARKET FORECAST (2022-2027)
7.1 Global Neurological Biomarkers Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neurological Biomarkers Price and Trend Forecast (2022-2027)
7.2 Global Neurological Biomarkers Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neurological Biomarkers Revenue and Growth Rate of Alzheimer's disease (AD) (2022-2027)
7.3.2 Global Neurological Biomarkers Revenue and Growth Rate of Multiple sclerosis (MS) (2022-2027)
7.3.3 Global Neurological Biomarkers Revenue and Growth Rate of Parkinson's disease (PD) (2022-2027)
7.3.4 Global Neurological Biomarkers Revenue and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
7.4 Global Neurological Biomarkers Consumption Forecast by Application (2022-2027)
7.4.1 Global Neurological Biomarkers Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Neurological Biomarkers Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Neurological Biomarkers Consumption Value and Growth Rate of Diagnostic and research laboratories(2022-2027)
7.5 Neurological Biomarkers Market Forecast Under COVID-19
8 NEUROLOGICAL BIOMARKERS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neurological Biomarkers Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neurological Biomarkers Analysis
8.6 Major Downstream Buyers of Neurological Biomarkers Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neurological Biomarkers Industry
9 PLAYERS PROFILES
9.1 QIAGEN
9.1.1 QIAGEN Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neurological Biomarkers Product Profiles, Application and Specification
9.1.3 QIAGEN Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Aepodia
9.2.1 Aepodia Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neurological Biomarkers Product Profiles, Application and Specification
9.2.3 Aepodia Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Athena Diagnostics
9.3.1 Athena Diagnostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neurological Biomarkers Product Profiles, Application and Specification
9.3.3 Athena Diagnostics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Quanterix
9.4.1 Quanterix Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neurological Biomarkers Product Profiles, Application and Specification
9.4.3 Quanterix Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AbaStar MDx
9.5.1 AbaStar MDx Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Neurological Biomarkers Product Profiles, Application and Specification
9.5.3 AbaStar MDx Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Acumen Pharmaceuticals
9.6.1 Acumen Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Neurological Biomarkers Product Profiles, Application and Specification
9.6.3 Acumen Pharmaceuticals Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Myriad RBM
9.7.1 Myriad RBM Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Neurological Biomarkers Product Profiles, Application and Specification
9.7.3 Myriad RBM Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Cisbio Bioassays
9.8.1 Cisbio Bioassays Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Neurological Biomarkers Product Profiles, Application and Specification
9.8.3 Cisbio Bioassays Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Proteome Sciences
9.9.1 Proteome Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Neurological Biomarkers Product Profiles, Application and Specification
9.9.3 Proteome Sciences Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 ImmunArray
9.10.1 ImmunArray Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Neurological Biomarkers Product Profiles, Application and Specification
9.10.3 ImmunArray Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Abiant
9.11.1 Abiant Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Neurological Biomarkers Product Profiles, Application and Specification
9.11.3 Abiant Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Thermo Fisher Scientific
9.12.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Neurological Biomarkers Product Profiles, Application and Specification
9.12.3 Thermo Fisher Scientific Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Neurological Biomarkers Market
1.2 Neurological Biomarkers Market Segment by Type
1.2.1 Global Neurological Biomarkers Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neurological Biomarkers Market Segment by Application
1.3.1 Neurological Biomarkers Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neurological Biomarkers Market, Region Wise (2017-2027)
1.4.1 Global Neurological Biomarkers Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.3 Europe Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.4 China Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.5 Japan Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.6 India Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.8 Latin America Neurological Biomarkers Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neurological Biomarkers Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neurological Biomarkers (2017-2027)
1.5.1 Global Neurological Biomarkers Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neurological Biomarkers Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neurological Biomarkers Market
2 INDUSTRY OUTLOOK
2.1 Neurological Biomarkers Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neurological Biomarkers Market Drivers Analysis
2.4 Neurological Biomarkers Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neurological Biomarkers Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neurological Biomarkers Industry Development
3 GLOBAL NEUROLOGICAL BIOMARKERS MARKET LANDSCAPE BY PLAYER
3.1 Global Neurological Biomarkers Sales Volume and Share by Player (2017-2022)
3.2 Global Neurological Biomarkers Revenue and Market Share by Player (2017-2022)
3.3 Global Neurological Biomarkers Average Price by Player (2017-2022)
3.4 Global Neurological Biomarkers Gross Margin by Player (2017-2022)
3.5 Neurological Biomarkers Market Competitive Situation and Trends
3.5.1 Neurological Biomarkers Market Concentration Rate
3.5.2 Neurological Biomarkers Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROLOGICAL BIOMARKERS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neurological Biomarkers Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neurological Biomarkers Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neurological Biomarkers Market Under COVID-19
4.5 Europe Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neurological Biomarkers Market Under COVID-19
4.6 China Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neurological Biomarkers Market Under COVID-19
4.7 Japan Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neurological Biomarkers Market Under COVID-19
4.8 India Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neurological Biomarkers Market Under COVID-19
4.9 Southeast Asia Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neurological Biomarkers Market Under COVID-19
4.10 Latin America Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neurological Biomarkers Market Under COVID-19
4.11 Middle East and Africa Neurological Biomarkers Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neurological Biomarkers Market Under COVID-19
5 GLOBAL NEUROLOGICAL BIOMARKERS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neurological Biomarkers Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neurological Biomarkers Revenue and Market Share by Type (2017-2022)
5.3 Global Neurological Biomarkers Price by Type (2017-2022)
5.4 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Alzheimer's disease (AD) (2017-2022)
5.4.2 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Multiple sclerosis (MS) (2017-2022)
5.4.3 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Parkinson's disease (PD) (2017-2022)
5.4.4 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
6 GLOBAL NEUROLOGICAL BIOMARKERS MARKET ANALYSIS BY APPLICATION
6.1 Global Neurological Biomarkers Consumption and Market Share by Application (2017-2022)
6.2 Global Neurological Biomarkers Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neurological Biomarkers Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2017-2022)
7 GLOBAL NEUROLOGICAL BIOMARKERS MARKET FORECAST (2022-2027)
7.1 Global Neurological Biomarkers Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neurological Biomarkers Price and Trend Forecast (2022-2027)
7.2 Global Neurological Biomarkers Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neurological Biomarkers Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neurological Biomarkers Revenue and Growth Rate of Alzheimer's disease (AD) (2022-2027)
7.3.2 Global Neurological Biomarkers Revenue and Growth Rate of Multiple sclerosis (MS) (2022-2027)
7.3.3 Global Neurological Biomarkers Revenue and Growth Rate of Parkinson's disease (PD) (2022-2027)
7.3.4 Global Neurological Biomarkers Revenue and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
7.4 Global Neurological Biomarkers Consumption Forecast by Application (2022-2027)
7.4.1 Global Neurological Biomarkers Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Neurological Biomarkers Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Neurological Biomarkers Consumption Value and Growth Rate of Diagnostic and research laboratories(2022-2027)
7.5 Neurological Biomarkers Market Forecast Under COVID-19
8 NEUROLOGICAL BIOMARKERS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neurological Biomarkers Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neurological Biomarkers Analysis
8.6 Major Downstream Buyers of Neurological Biomarkers Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neurological Biomarkers Industry
9 PLAYERS PROFILES
9.1 QIAGEN
9.1.1 QIAGEN Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neurological Biomarkers Product Profiles, Application and Specification
9.1.3 QIAGEN Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Aepodia
9.2.1 Aepodia Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neurological Biomarkers Product Profiles, Application and Specification
9.2.3 Aepodia Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Athena Diagnostics
9.3.1 Athena Diagnostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neurological Biomarkers Product Profiles, Application and Specification
9.3.3 Athena Diagnostics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Quanterix
9.4.1 Quanterix Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neurological Biomarkers Product Profiles, Application and Specification
9.4.3 Quanterix Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AbaStar MDx
9.5.1 AbaStar MDx Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Neurological Biomarkers Product Profiles, Application and Specification
9.5.3 AbaStar MDx Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Acumen Pharmaceuticals
9.6.1 Acumen Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Neurological Biomarkers Product Profiles, Application and Specification
9.6.3 Acumen Pharmaceuticals Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Myriad RBM
9.7.1 Myriad RBM Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Neurological Biomarkers Product Profiles, Application and Specification
9.7.3 Myriad RBM Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Cisbio Bioassays
9.8.1 Cisbio Bioassays Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Neurological Biomarkers Product Profiles, Application and Specification
9.8.3 Cisbio Bioassays Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Proteome Sciences
9.9.1 Proteome Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Neurological Biomarkers Product Profiles, Application and Specification
9.9.3 Proteome Sciences Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 ImmunArray
9.10.1 ImmunArray Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Neurological Biomarkers Product Profiles, Application and Specification
9.10.3 ImmunArray Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Abiant
9.11.1 Abiant Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Neurological Biomarkers Product Profiles, Application and Specification
9.11.3 Abiant Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Thermo Fisher Scientific
9.12.1 Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Neurological Biomarkers Product Profiles, Application and Specification
9.12.3 Thermo Fisher Scientific Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Neurological Biomarkers Product Picture
Table Global Neurological Biomarkers Market Sales Volume and CAGR (%) Comparison by Type
Table Neurological Biomarkers Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neurological Biomarkers Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neurological Biomarkers Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neurological Biomarkers Industry Development
Table Global Neurological Biomarkers Sales Volume by Player (2017-2022)
Table Global Neurological Biomarkers Sales Volume Share by Player (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Share by Player in 2021
Table Neurological Biomarkers Revenue (Million USD) by Player (2017-2022)
Table Neurological Biomarkers Revenue Market Share by Player (2017-2022)
Table Neurological Biomarkers Price by Player (2017-2022)
Table Neurological Biomarkers Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurological Biomarkers Sales Volume, Region Wise (2017-2022)
Table Global Neurological Biomarkers Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share, Region Wise in 2021
Table Global Neurological Biomarkers Revenue (Million USD), Region Wise (2017-2022)
Table Global Neurological Biomarkers Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share, Region Wise in 2021
Table Global Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neurological Biomarkers Sales Volume by Type (2017-2022)
Table Global Neurological Biomarkers Sales Volume Market Share by Type (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share by Type in 2021
Table Global Neurological Biomarkers Revenue (Million USD) by Type (2017-2022)
Table Global Neurological Biomarkers Revenue Market Share by Type (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share by Type in 2021
Table Neurological Biomarkers Price by Type (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Alzheimer's disease (AD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Multiple sclerosis (MS) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Parkinson's disease (PD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
Table Global Neurological Biomarkers Consumption by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Market Share by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Revenue Market Share by Application (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neurological Biomarkers Price and Trend Forecast (2022-2027)
Figure USA Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neurological Biomarkers Market Sales Volume Forecast, by Type
Table Global Neurological Biomarkers Sales Volume Market Share Forecast, by Type
Table Global Neurological Biomarkers Market Revenue (Million USD) Forecast, by Type
Table Global Neurological Biomarkers Revenue Market Share Forecast, by Type
Table Global Neurological Biomarkers Price Forecast, by Type
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
Table Global Neurological Biomarkers Market Consumption Forecast, by Application
Table Global Neurological Biomarkers Consumption Market Share Forecast, by Application
Table Global Neurological Biomarkers Market Revenue (Million USD) Forecast, by Application
Table Global Neurological Biomarkers Revenue Market Share Forecast, by Application
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Diagnostic and research laboratories (2022-2027)
Figure Neurological Biomarkers Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table QIAGEN Profile
Table QIAGEN Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure QIAGEN Neurological Biomarkers Sales Volume and Growth Rate
Figure QIAGEN Revenue (Million USD) Market Share 2017-2022
Table Aepodia Profile
Table Aepodia Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aepodia Neurological Biomarkers Sales Volume and Growth Rate
Figure Aepodia Revenue (Million USD) Market Share 2017-2022
Table Athena Diagnostics Profile
Table Athena Diagnostics Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Athena Diagnostics Neurological Biomarkers Sales Volume and Growth Rate
Figure Athena Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Quanterix Profile
Table Quanterix Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quanterix Neurological Biomarkers Sales Volume and Growth Rate
Figure Quanterix Revenue (Million USD) Market Share 2017-2022
Table AbaStar MDx Profile
Table AbaStar MDx Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbaStar MDx Neurological Biomarkers Sales Volume and Growth Rate
Figure AbaStar MDx Revenue (Million USD) Market Share 2017-2022
Table Acumen Pharmaceuticals Profile
Table Acumen Pharmaceuticals Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acumen Pharmaceuticals Neurological Biomarkers Sales Volume and Growth Rate
Figure Acumen Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Myriad RBM Profile
Table Myriad RBM Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Myriad RBM Neurological Biomarkers Sales Volume and Growth Rate
Figure Myriad RBM Revenue (Million USD) Market Share 2017-2022
Table Cisbio Bioassays Profile
Table Cisbio Bioassays Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cisbio Bioassays Neurological Biomarkers Sales Volume and Growth Rate
Figure Cisbio Bioassays Revenue (Million USD) Market Share 2017-2022
Table Proteome Sciences Profile
Table Proteome Sciences Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Proteome Sciences Neurological Biomarkers Sales Volume and Growth Rate
Figure Proteome Sciences Revenue (Million USD) Market Share 2017-2022
Table ImmunArray Profile
Table ImmunArray Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ImmunArray Neurological Biomarkers Sales Volume and Growth Rate
Figure ImmunArray Revenue (Million USD) Market Share 2017-2022
Table Abiant Profile
Table Abiant Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abiant Neurological Biomarkers Sales Volume and Growth Rate
Figure Abiant Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific Profile
Table Thermo Fisher Scientific Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific Neurological Biomarkers Sales Volume and Growth Rate
Figure Thermo Fisher Scientific Revenue (Million USD) Market Share 2017-2022
Figure Neurological Biomarkers Product Picture
Table Global Neurological Biomarkers Market Sales Volume and CAGR (%) Comparison by Type
Table Neurological Biomarkers Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neurological Biomarkers Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neurological Biomarkers Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neurological Biomarkers Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neurological Biomarkers Industry Development
Table Global Neurological Biomarkers Sales Volume by Player (2017-2022)
Table Global Neurological Biomarkers Sales Volume Share by Player (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Share by Player in 2021
Table Neurological Biomarkers Revenue (Million USD) by Player (2017-2022)
Table Neurological Biomarkers Revenue Market Share by Player (2017-2022)
Table Neurological Biomarkers Price by Player (2017-2022)
Table Neurological Biomarkers Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurological Biomarkers Sales Volume, Region Wise (2017-2022)
Table Global Neurological Biomarkers Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share, Region Wise in 2021
Table Global Neurological Biomarkers Revenue (Million USD), Region Wise (2017-2022)
Table Global Neurological Biomarkers Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share, Region Wise (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share, Region Wise in 2021
Table Global Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neurological Biomarkers Sales Volume by Type (2017-2022)
Table Global Neurological Biomarkers Sales Volume Market Share by Type (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share by Type in 2021
Table Global Neurological Biomarkers Revenue (Million USD) by Type (2017-2022)
Table Global Neurological Biomarkers Revenue Market Share by Type (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share by Type in 2021
Table Neurological Biomarkers Price by Type (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Alzheimer's disease (AD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Multiple sclerosis (MS) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Parkinson's disease (PD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2017-2022)
Table Global Neurological Biomarkers Consumption by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Market Share by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neurological Biomarkers Consumption Revenue Market Share by Application (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Clinics (2017-2022)
Table Global Neurological Biomarkers Consumption and Growth Rate of Diagnostic and research laboratories (2017-2022)
Figure Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neurological Biomarkers Price and Trend Forecast (2022-2027)
Figure USA Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Biomarkers Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neurological Biomarkers Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neurological Biomarkers Market Sales Volume Forecast, by Type
Table Global Neurological Biomarkers Sales Volume Market Share Forecast, by Type
Table Global Neurological Biomarkers Market Revenue (Million USD) Forecast, by Type
Table Global Neurological Biomarkers Revenue Market Share Forecast, by Type
Table Global Neurological Biomarkers Price Forecast, by Type
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Alzheimer's disease (AD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Multiple sclerosis (MS) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Parkinson's disease (PD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate of Autism spectrum disorder (ASD) (2022-2027)
Table Global Neurological Biomarkers Market Consumption Forecast, by Application
Table Global Neurological Biomarkers Consumption Market Share Forecast, by Application
Table Global Neurological Biomarkers Market Revenue (Million USD) Forecast, by Application
Table Global Neurological Biomarkers Revenue Market Share Forecast, by Application
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Neurological Biomarkers Consumption Value (Million USD) and Growth Rate of Diagnostic and research laboratories (2022-2027)
Figure Neurological Biomarkers Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table QIAGEN Profile
Table QIAGEN Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure QIAGEN Neurological Biomarkers Sales Volume and Growth Rate
Figure QIAGEN Revenue (Million USD) Market Share 2017-2022
Table Aepodia Profile
Table Aepodia Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aepodia Neurological Biomarkers Sales Volume and Growth Rate
Figure Aepodia Revenue (Million USD) Market Share 2017-2022
Table Athena Diagnostics Profile
Table Athena Diagnostics Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Athena Diagnostics Neurological Biomarkers Sales Volume and Growth Rate
Figure Athena Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Quanterix Profile
Table Quanterix Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quanterix Neurological Biomarkers Sales Volume and Growth Rate
Figure Quanterix Revenue (Million USD) Market Share 2017-2022
Table AbaStar MDx Profile
Table AbaStar MDx Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbaStar MDx Neurological Biomarkers Sales Volume and Growth Rate
Figure AbaStar MDx Revenue (Million USD) Market Share 2017-2022
Table Acumen Pharmaceuticals Profile
Table Acumen Pharmaceuticals Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acumen Pharmaceuticals Neurological Biomarkers Sales Volume and Growth Rate
Figure Acumen Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Myriad RBM Profile
Table Myriad RBM Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Myriad RBM Neurological Biomarkers Sales Volume and Growth Rate
Figure Myriad RBM Revenue (Million USD) Market Share 2017-2022
Table Cisbio Bioassays Profile
Table Cisbio Bioassays Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cisbio Bioassays Neurological Biomarkers Sales Volume and Growth Rate
Figure Cisbio Bioassays Revenue (Million USD) Market Share 2017-2022
Table Proteome Sciences Profile
Table Proteome Sciences Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Proteome Sciences Neurological Biomarkers Sales Volume and Growth Rate
Figure Proteome Sciences Revenue (Million USD) Market Share 2017-2022
Table ImmunArray Profile
Table ImmunArray Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ImmunArray Neurological Biomarkers Sales Volume and Growth Rate
Figure ImmunArray Revenue (Million USD) Market Share 2017-2022
Table Abiant Profile
Table Abiant Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abiant Neurological Biomarkers Sales Volume and Growth Rate
Figure Abiant Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific Profile
Table Thermo Fisher Scientific Neurological Biomarkers Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific Neurological Biomarkers Sales Volume and Growth Rate
Figure Thermo Fisher Scientific Revenue (Million USD) Market Share 2017-2022
